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T ype 2 diabetes mellitus (T2DM) is caused by impaired insulin secretion and/or insulin resis-
tance,  resulting in chronic high-glucose levels.  Proper 
glycemic control is a critical therapeutic approach,  and 
exercise (e.g.,  walking and jogging) is one of the major 
therapeutic approaches to T2DM treatment in clinical 
practice.  Resistance training has also been effective for 
individuals with T2DM,  and it was shown to improve 
glycemic control [1-3] by increasing muscle strength 
[4 , 5].  However,  several of these studies targeted major 
muscles,  and to our knowledge there has been no 
investigation focusing on toe pinch force (TPF).
TPF is essential for postural stability during standing 
and/or walking [6 , 7] and in the propulsive force of gait 
[8].  Several studies have demonstrated that TPF 
decreases with aging [6 , 9 , 10],  and decreasing TPF is 
closely linked to falls in elderly people [7 , 11 , 12] 
Despite its importance,  TPF has not been adequately 
addressed in clinical practice compared to other muscle 
parameters such as lower limb muscle strength.  In 
patients with T2DM,  a lower TPF value leads to a 
higher risk of falls and fractures,  which in turn can 
result in decreased activities of daily living and/or 
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Resistance training is effective against type 2 diabetes (T2DM),  but the effect of resistance training on toe pinch 
force (TPF) is unknown.  Here we investigated the effect of short-term toe resistance training on TPF in patients 
with T2DM,  in a prospective,  parallel-group,  single-blind,  randomized controlled trial.  Twelve patients with 
T2DM who were hospitalized to improve glycemic control were enrolled.  The patients were randomly allocated 
to the intervention (n = 6) and control (n = 6) groups.  The intervention group performed traditional aerobic 
exercise and 4 newly developed toe-resistance training exercises.  The control group performed aerobic exercise 
only.  After 2 weeks of the exercise intervention program,  we evaluated anthropometric parameters,  clinical 
parameters,  motor function,  and muscle parameters in each patient.  After the exercise intervention program,  
the TPF and toe muscle quality,  isometric knee extension force,  and knee muscle quality were significantly 
higher in the intervention group compared to the control group.  Two weeks of toe-resistance training signifi-
cantly increased the TPF in the T2DM patients.  Toe resistance training is thus recommended in clinical practice 
for patients with T2DM.
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reduced quality of life.  Therefore,  evaluations of the 
effect of toe resistance training on TPF in patients with 
T2DM could provide useful information.
We demonstrated higher internal reproducibility 
and the correlation between TPF and other muscle 
strength parameters (external reproducibility) by using 
a newly developed TPF measurement procedure 
[13 , 14].  We also observed that the TPF in patients with 
T2DM was significantly lower than that in patients 
without diabetes [15].  In another study,  we also 
explored a short-term toe resistance training program 
that consists of 4 sessions,  and the results demonstrated 
that TPF was significantly improved after the training 
program [16].
We conducted the present prospective,  parallel- 
group,  single-blind,  randomized controlled trial (RCT) 
to determine the effect of short-term toe resistance 
training on the TPF in patients with T2DM.
Patients and Methods
Study design. This study was a prospective,  par-
allel-group,  single-blind,  RCT of Japanese patients with 
T2DM,  all of whom provided written informed consent 
to participate.  We randomly assigned the patients into 
the intervention and control groups.  The research eth-
ics committee of KKR Takamatsu Hospital approved 
this study (Approval no. E112).  The original study pro-
tocol was registered in the University Hospital Medical 
Information Network (UMIN000026488).
Study subjects. The study populations was 12 
patients with T2DM (nine men and three women,  age 
63.8 ± 12.0 years,  and duration of T2DM 9.4 ± 8.2 years) 
who were hospitalized for 2 weeks from January 23 to 
April 15,  2017 at KKR Takamatsu Hospital,  Kagawa,  
Japan,  for glycemic control (Tables 1 , 2).  The study was 
conducted at a rehabilitation center in KKR Takamatsu 
Hospital.  The patients were randomly assigned into 
intervention and control groups (Fig. 1).  The exclusion 
criteria included the following: severe cardiac or lung 
disease,  acute or chronic musculoskeletal disorders,  
acute metabolic dysregulation,  other neurological or 
endocrine disorders,  a history of stroke,  metal implants 
such as bolts and metallic prosthetic joints,  placement 
of a stent and/or pacemaker,  previous or current asym-
metric proximal lower leg weakness,  and toe deformity 
or atrophy of foot muscles,  as described [16].
Sample size calculation. In our earlier investiga-
tion [16],  toe resistance training increased the TPF in 
patients with T2DM from 2.92 ± 1.19 to 3.65 ± 1.58 kg,  
indicating that the patients were able to improve their 
TPF by an average of 0.73 kg.  We assumed a standard 
deviation of 0.37 of the response variable.  Twelve 
patients were needed for 80% probability that the study 
would detect treatment differences at a two-sided 5% 
significance level.
Exercise intervention program and toe-resistance 
training exercises. The intervention group performed 
traditional aerobic exercise in the afternoon and four toe 
resistance training exercises [16] in the morning.  The 
control group performed traditional aerobic exercise 
only,  in the afternoon.  The aerobic exercise was per-
formed with a bicycle ergometer (AEROBIKE 2100R,  
Minato Medical Science Co. Osaka,  Japan).  The exer-
cise intensity setting was calculated with the Karvonen 
method [16],  and the exercise load was set at a moder-
ate level.  The exercise was performed 2 h after lunch for 
30 min.
The 4 toe resistance training exercises were as fol-
lows [16]: (1) picking up a towel using toe fingers,  (2) 
bending the toe fingers with a rubber tube,  (3) bending 
the toe fingers with a rubber ball,  and (4) grasping a 
small stick using the toe fingers.  All procedures were 
performed 20 times by each foot with 3 sets every day 
for 2 weeks.  Each of the 4 types of toe resistance train-
ing was performed at ≥ 5-min intervals.  During the 
weekends,  the patients walked around the hospital,  and 
the toe resistance training was performed in their hos-
pital rooms.
Measurement of muscle strength, skeletal muscle 
mass, and motor function. The TPF measurements 
were performed using “Checker-kun,” as described [13-
16].  Each patient’s handgrip strength,  isometric knee 
extension force (KEF),  skeletal muscle mass,  knee 
muscle quality (KMQ),  and toe muscle quality (TMQ),  
which are expressed as the ratio of the strength to the 
corresponding lower limb muscle mass in kilograms,  
were also measured as described [14 , 16].  All of these 
parameters were measured twice,  and the best records 
of the left and right arms and legs were averaged [14].
To evaluate motor function,  we administered the 
single-leg standing test <http://www.mext.go.jp/com-
ponent/a_menu/sports/detail/_icsFiles/afieldfile/ 
2010/07/30/1295079_04.pdf>,  accessed 23 December 
2016. (in Japanese),  a functional reach test [17],  and a 
walking speed test [18] as described.
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Clinical and laboratory measurements. We col-
lected data on each patient’s age,  height,  body weight,  
body mass index (BMI),  duration of T2DM,  systolic 
blood pressure,  diastolic blood pressure,  heart rate 
(HR),  ankle-brachial index (ABI),  cardio-ankle vascu-
lar index (CAVI),  medications,  and laboratory test 
results.  The patients’ levels of fasting plasma glucose 
(FBG),  hemoglobin A1c (HbA1c),  total cholesterol,  
low-density lipoprotein cholesterol,  high-density lipo-
protein cholesterol,  triglycerides,  serum creatinine,  
and albumin,  the estimated glomerular filtration rate 
and the serum C-peptide immunoreactivity (S-CPR) 
were measured by standard laboratory methods.  Well-
trained medical staff interviewed each patient using the 
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Table 1　 Clinical characteristics of the intervention and control groups
Control Intervention p-value
n (Male) 6 (3) 6 (6)
Age (years) 66.8±9.8 60.8±14.2 0.521
Height (cm) 159.9±10.0 165.1±0.1 0.336
Body weight (kg) 74.3±20.6 69.8±10.0 0.936
BMI (kg/m2) 28.8±5.9 25.5±2.4 0.471
SBP (mmHg) 137.8±9.2 125.2±16.0 0.172
DBP (mmHg) 86.5±6.9 74.5±9.8 0.064
HR (beat/min) 80.2±8.8 72.0±10.5 0.108
Duration of type 2 diabetes (years) 9.8±8.9 9.0±8.4 0.935
IPAQ (kcal/day) 100.5±120.8 182.6±138.7 0.298
HbA1c (%) 9.7±1.5 12.2±2.5 0.128
FBG (mg/dL) 172.5±43.3 211.0±43.7 0.149
Total cholesterol (mg/dL) 189.7±33.4 199.8±35.7 0.810
Triglyceride (mg/dL) 145.5±48.5 217.2±171.3 1.000
HDL-cholesterol (mg/dL) 51.2±10.3 45.5±10.6 0.377
LDL-cholesterol (mg/dL) 115.7±39.5 116.7±30.9 1.000
Serum creatinine (mg/dL) 0.76±0.25 0.93±0.48 0.575
Albuminuria (mg/g・CRE) 12.3±10.4 7.52±6.5 0.379
eGFR (mL/min/1.73m2) 72.9±25.7 80.4±29.6 0.575
S-CPR (fasting) (ng/mL) 2.07±0.90 1.38±0.50 0.091
S-CPR (postprandial) (ng/mL) 4.33±1.88 2.25±0.68 0.031
ABI 1.13±0.07 1.08±0.01 0.172
CAVI 8.5±1.6 8.4±1.2 0.936
Drinking habit (n) 4 2 0.557
Smoking habit
　Current smoker (n) 0 1
0.153　Previous smoker (n) 1 3
　Non smoker (n) 5 2
Exercise habit (n) 3 3 －
Neuropathy (n) 1 1 －
Retinopathy
　None (n) 5 6 0.224
　Simple (n) 1 0
Nephropathy
　Stage 1 (n) 6 6 －
Drug therapy
　none 1 0
0.041
　Insulin (n) 0 3
　OHA (n) 5 2
　Iinsulin and OHA (n) 0 1
Value are presented as mean ± SD.  Bold values indicate p＜0.05.
BMI,  body mass index; SBP,  systolic blood pressure; DBP,  diastolic blood pressure; HR,  heart rate; IPAQ,  international physical activ-
ity questionnaire; FBG,  fasting blood glucose; eGFR,  estimated glomerular ﬁltration rate; S-CPR,  Serum C-peptide immunoreactivity;  
ABI,  ankle-brachial index; CAVI,  cardio-ankle vascular index; OHA,  oral hypoglycemic agent.
International Physical Activity Questionnaire (Short 
Version) [19] and to evaluate the patient’s drinking,  
smoking,  and exercise habits.  Blood pressure (BP) and 
HR were measured with an HBR-2070 device (Omron 
Colin,  Tokyo,  Japan).  The ABI and CAVI were mea-
sured with a VS-1500 device (Fukuda Denshi,  Tokyo,  
Japan).  Body weight,  FBG,  BMI,  BP,  HR,  motor 
function,  and muscle parameters were also evaluated at 
the time of hospital discharge.
The diagnosis of T2DM was based on FBG and 
HbA1c levels as reported [16] and was performed 
according to the guidelines of the Japan Diabetes 
Society (JDS) [20].  Diabetic retinopathy,  nephropathy,  
and neuropathy were also defined based on the diag-
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Table 2　 Motor function and muscle parameters of the intervention group and control groups
Control (n＝6) Intervention (n＝6) p-value
Motor function
　Single-leg standing (open eyes) (sec) 22.4±26.3 42.6±30.2 0.230
　Single-leg standing (closed eyes) (sec) 5.87±5.82 5.71±8.04 0.575
　Functional reach (cm) 29.8±3.3 35.8±6.0 0.147
　Comfortable walking speed (m/sec) 1.10±0.25 1.21±0.24 0.379
　　Walking rate (steps/sec) 1.93±0.35 1.95±0.18 1.000
　Maximum walking speed (m/sec) 1.57±0.51 1.88±0.67 0.337
　　Walking rate (steps/sec) 2.54±0.39 2.50±0.41 1.000
Muscle strength
　Handgrip strength (kg) 26.1±5.1 33.3±7.5 0.093
　Knee extension force (kgf) 26.1±10.7 39.9±6.9 0.066
　Knee muscle quality (kgf/kg) 6.7±1.5 10.5±1.9 0.013
　Toe pinch force (kg) 3.50±1.09 4.48±0.90 0.174
　Toe muscle quality (kg/kg) 2.68±0.72 3.35±0.90 0.298
Skeletal muscle mass
　Upper extremity (kg) 1.13±0.34 1.25±0.20 0.689
　　Brachial region (kg) 0.68±0.23 0.74±0.18 0.689
　　Antebrachial region (kg) 0.45±0.11 0.50±0.07 0.471
　Lower extremity (kg) 5.26±1.71 5.23±0.73 0.689
　　Femoral region (kg) 3.83±1.25 3.85±0.46 0.936
　　Leg region (kg) 1.32±0.28 1.38±0.31 0.688
Value are presented as mean ± SD.  Bold values indicate p＜0.05.
112 Patients assessed for eligibility
6 Randomized to the intervention group
　－ Aerobic exercise and toe resistance training
12 Randomized
6 Included in the primary analysis 6 Included in the primary analysis
6 Randomized to the control group
　 － Aerobic exercise
100 Patients excluded
　84 Patients met the exclusion criteria
　12 Declined to participate
　 4 Other
Fig. 1　 Flow diagram of the T2DM patients enrolled in the study.
nostic guidelines of the JDS [20].
Outcome measures. The primary outcome of this 
study was the effect of the short-term (2-week) toe 
resistance training on TPF.  The secondary outcomes 
included TMQ,  glycemic control,  and motor function.
Statistical analysis. Data are expressed as the 
mean ± standard deviation.  The Mann-Whitney U-test 
and χ2 test were used to compare the clinical parame-
ters between the control and intervention groups at 
baseline.  The comparison of parameters between the 2 
groups after the 2-week program was performed using 
the Mann-Whitney U-test,  and p-values < 0.05 were 
considered significant.  All data were analyzed using 
JMP 12.2.0 software (SAS Institute,  Cary,  NC,  USA).
Results
Twelve Japanese patients with T2DM were recruited 
and randomly assigned into the intervention group 
(n = 6) and the control group (n = 6).  At baseline,  the 
TPF in the intervention group was 4.48 ± 0.90 kg,  and 
that in the control group was 3.50 ± 1.09 kg.  Significant 
between-group differences in the baseline KMQ values 
(p = 0.013) and postprandial S-CPR level (p = 0.031) 
were noted.  However,  the other parameters showed no 
significant difference between the groups at baseline 
(Table 2).
The values of the parameters in the control and 
intervention groups at the end of the exercise interven-
tion program are summarized in Table 3.  After the 
exercise intervention program,  the TPF of the interven-
tion group was significantly higher than that of the 
control group (5.18 ± 0.74 vs. 3.44 ± 0.65 kg,  p = 0.008).  
The TMQ,  KEF,  and KMQ values of the intervention 
group were also significantly higher than those of the 
control group.
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Table 3　 Clinical characteristics,  motor function,  and muscle parameter after exercise intervention program
Mean ±  SD (95% CI)
p-value
Control (n＝6) Intervention (n＝6)
　Body weight (kg) 72.0±19.2 (51.9 to 92.2) 69.2±10.5 (58.3 to 80.3) 1.000
　BMI (kg/m2) 28.1±5.5 (22.4 to 33.9) 25.3±2.5　 (22.7 to 28.0) 0.336
　FBG (mg/dL) 126.2±10.2 (115.5 to 136.9) 125.3±30.5 (93.3 to 157.4) 0.873
　SBP (mmHg) 129.2±12.1 (116.5 to 141.9) 116.7±15.0 (100.9 to 132.4) 0.119
　DBP (mmHg) 76.8±6.8 (69.7 to 84.0) 69.3±16.8 (51.7 to 87.0) 0.422
　HR (beat/min) 79.0±9.6 (68.9 to 89.1) 66.5±9.9　 (56.1 to 76.9) 0.093
Motor function
　Single-leg standing (open eyes) (sec) 17.4±19.9 (－3.50 to 38.3) 39.5±30.0 (8.06 to 71.0) 0.575
　Single-leg standing (closed eyes) (sec) 3.69±2.62 (0.93 to 6.44) 5.89±6.34 (－0.76 to 12.54) 0.810
　Functional reach (cm) 31.0±3.9 (26.9 to 35.1) 33.9±7.0　 (26.6 to 41.3) 0.336
　Comfortable walking speed (m/sec) 1.26±0.20 (1.05 to 1.47) 1.34±0.22 (1.11 to 1.56) 0.936
　　Walking rate (steps/sec) 1.93±0.62 (1.65 to 2.20) 1.97±0.12 (1.84 to 2.09) 0.689
　Maximum walking speed (m/sec) 1.72±0.31 (1.39 to 2.05) 2.24±0.54 (1.67 to 2.80) 0.128
　　Walking rate (steps/sec) 2.39±0.35 (2.02 to 2.76) 2.67±0.73 (1.90 to 3.44) 0.630
Muscle strength
　Handgrip strength (kg) 27.1±4.7 (22.1 to 32.0) 36.0±7.0　 (28.7 to 43.3) 0.065
　Knee extension force (kgf) 27.4±11.5 (15.3 to 39.5) 45.0±10.4 (34.0 to 55.9) 0.031
　Knee muscle quality (kgf/kg) 7.2±1.5 (5.6 to 8.8) 11.8±2.1　 (9.5 to 14.1) 0.031
　Toe pinch force (kg) 3.44±0.65 (2.76 to 4.12) 5.18±0.74 (4.40 to 5.95) 0.008
　Toe muscle quality (kg/kg) 2.76±0.45 (2.30 to 3.23) 3.88±0.91 (2.92 to 4.83) 0.020
Skeletal muscle mass
　　Upper extremity (kg) 1.09±0.37 (0.70 to 1.48) 1.25±0.21 (1.03 to 1.48) 0.471
　　Brachial region (kg) 0.64±0.21 (0.42 to 0.87) 0.77±0.17 (0.59 to 0.95) 0.336
　　Antebrachial region (kg) 0.47±0.13 (0.34 to 0.61) 0.48±0.06 (0.42 to 0.54) 0.575
　lower extremity (kg) 5.06±1.54 (3.44 to 6.68) 5.19±0.75 (4.40 to 5.97) 0.689
　　Femoral region (kg) 3.79±1.26 (2.47 to 5.10) 3.79±0.50 (3.27 to 4.32) 0.575
　　Leg region (kg) 1.27±0.31 (0.94 to 1.60) 1.39±0.35 (1.02 to 1.76) 0.748
BMI,  body mass index; FBG,  fasting blood glucose; SBP,  systolic blood pressure; DBP,  diastolic blood pressure; HR,  heart rate.
Bold values indicate p＜0.05.
Discussion
We evaluated the effect of short-term toe resistance 
training on the TPF in patients with T2DM in a ran-
domized controlled trial.  Our analyses demonstrated 
that the TPF as a main outcome in the intervention 
group was significantly higher than that in the control 
group after the intervention.  Moreover,  significantly 
higher levels of the secondary outcomes TMQ,  KEF,  
and KMQ were also noted in the intervention group.  
Thus,  the force parameters of toe pinch force and iso-
metric knee extension force were higher in the inter-
vention group than in the control group after the inter-
vention.
During the initial stage of resistance training,  mus-
cle hypertrophy is not generally observed,  but only 
muscle strength increases,  as suggested by Kraemer et 
al.  [21],  who hypothesized that neural factor,  which 
increases and synchronizes the motor units of muscle 
fibers,  is closely associated with the initial increased 
muscle strength.  Moritani et al.  [22] reported that neu-
ral factor is associated with increasing muscle strength 
within approx.  3 weeks and muscle hypertrophy is 
observed after around 4 weeks.  In addition,  increasing 
muscle strength without muscle hypertrophy was 
reported in other studies [23 , 24].  In our present inves-
tigation,  no skeletal muscle mass changes in the femo-
ral region (pre: 3.85 ± 0.46,  post: 3.79 ± 0.50 kg) and 
leg region (pre: 1.38 ± 0.31,  post: 1.39 ± 0.35 kg) were 
identified (Tables 2 , 3).  In addition,  the muscle quality 
(muscle strength/skeletal muscle mass) of the toe and 
knee was significantly higher in the intervention group 
than in the control group,  which was consistent with 
the previous hypothesis.  Moreover,  the higher KEF in 
the intervention group compared to the control group 
after the 4 toe-resistance training exercises suggested 
that toe-resistance training could improve KEF without 
targeting it.  The four toe-resistance training exercises 
were easily performed and could be a useful exercise 
strategy in clinical practice.
Allet et al.  [25] showed that balance function and 
walking ability are significantly increased by a combina-
tion of resistance training,  balance training,  and walk-
ing for 12 weeks.  Richardson et al.  [26] reported that 
the results of single-leg standing test and functional 
reach test were significantly improved for 3 weeks by 
resistance training and balance training in patients with 
T2DM with diabetic neuropathy.  These results suggest 
that physical therapy could improve motor function in 
patients with T2DM.  In the present study,  however,  no 
differences in motor function based on the results of the 
single-leg standing test,  functional reach test,  and 
walking speed test were found.  Our training program 
was only 2 weeks long,  and was comprise of only toe 
resistance training (not other resistance and/or balance 
training) and walking exercise.  This may be why we did 
not observe an increase in motor function in this study.  
In patients with T2DM,  falls and fractures are common 
[27],  and a long-term program targeting improved 
motor function is vital.
The performance rate of exercise therapy is only 
52.3%,  as previously reported [28].  The effect of exer-
cise therapy requires a certain minimum period of time 
and continuous motivation.  Nevertheless,  our 2-week 
program increased the patients’ TPF,  TMQ,  KEF,  and 
KMQ,  and these improvements could help increase and 
maintain patients’ motivation for performing exercise 
therapy.  In addition,  the 4 toe-resistance training exer-
cises can be performed in a sitting position and can be 
done by patients with lower activity levels,  such as 
elderly people,  patients with lower limb pain and/or 
disability,  patients who cannot walk,  patients at high 
risk for falls,  and those with a diabetic foot.  Therefore,  
TPF training might be a useful therapeutic approach for 
patients with T2DM.
This study has potential limitations.  First,  patients 
with diabetic neuropathy were included.  The TPF and 
KEF in T2DM patients with diabetic neuropathy were 
reported to be significantly lower than those in T2DM 
patients without diabetic neuropathy [15 , 29],  but an 
association between TPF and diabetic neuropathy was 
not been identified in this study.  Second,  we evaluated 
only the short-term effects of toe resistance training.
In conclusion,  the short-term toe resistance training 
improved our T2DM patients’ toe pinch force as well as 
their toe muscle quality,  isometric knee extension force,  
and knee muscle quality,  which indicates that the pro-
gram could be a useful exercise strategy for individuals 
with T2DM.  Hence,  toe resistance training is recom-
mended in clinical practice for patients with T2DM.  
The long-term effect of the training program and the 
association between TPF and complications such as 
diabetic neuropathy must be evaluated in future studies.
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